The regulation of cancer and aging by methionine

蛋氨酸对癌症和衰老的调节

基本信息

  • 批准号:
    10750559
  • 负责人:
  • 金额:
    $ 61.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary Age-related diseases, including cancer, are the major causes of morbidity and mortality in Western society. While cancer in the genetically heterogeneous human population primarily occurs in the aged, cancer research to-date has primarily utilized young, inbred animals. As the effect of aging and host factors on cancer development and progression has grown increasingly evident, the limitations of this approach have become clear. Understanding how aging impacts cancer development, progression, and the response to interventions will provide mechanistic insights into the prevention and treatment of cancer as individuals grow older, and eventually will permit the development of new pharmacological approaches to this age-associated disease that will enable healthy aging. Here, we build on recent work by our team and others demonstrating that restricting dietary protein, or restriction of specific dietary amino acids, can extend the lifespan and healthspan of mice. We will utilize methionine restriction (MR), a dietary intervention that extends longevity and improves metabolic health in mice, and which in mouse xenograft studies has been shown to slow the progression of certain cancers, including breast cancer, the most common cancer in older women. Limitations of MR research to date include the fact that the effect of MR on healthspan is limited in scope, that the effects of MR have been studied only in a few young mouse strains, and that the cancer studies done to-date have exclusively relied on young hosts. Understanding how MR affects the healthspan, longevity, and natural development of breast cancer during the aging of genetically heterogeneous mice will provide valuable new insights into the potential application of MR-based interventions for the health, longevity and treatment of cancer in the genetically heterogeneous human population. We will use cutting edge techniques to isolate and characterize cancer initiating cells (CICs), examine how changes in levels of methionine and its metabolites affect the epigenome. We will use two breast tumor models to examine how host age impacts CICs, tumor growth and/or metastasis and the response to MR. Finally, we will determine the role of specific molecular sensors of methionine metabolites in the epigenetic and anti-cancer effects of MR during aging. The proposed work will address long- standing questions regarding the molecular mechanisms by which dietary components regulate healthy aging and cancer.
项目摘要 在西方国家,与癌症有关的疾病,包括癌症,是发病率和死亡率的主要原因。 社会虽然遗传异质性人群中的癌症主要发生在老年人中,但癌症 迄今为止的研究主要利用幼小的近亲繁殖动物。由于衰老和宿主因素对癌症的影响 发展和进步越来越明显,这种方法的局限性已经成为 清楚了解衰老如何影响癌症的发展,进展和对干预措施的反应 将为随着个体年龄的增长预防和治疗癌症提供机制性见解, 最终将允许开发新的药理学方法来治疗这种年龄相关疾病, 将使健康的老龄化。 在这里,我们建立在我们的团队和其他人最近的工作基础上,证明限制膳食蛋白质,或 限制特定的饮食氨基酸,可以延长小鼠的寿命和健康寿命。我们将利用 蛋氨酸限制(MR),一种延长寿命和改善小鼠代谢健康的饮食干预, 并且在小鼠异种移植研究中已显示其减缓某些癌症的进展,包括 乳腺癌是老年妇女最常见的癌症。迄今为止,MR研究的局限性包括以下事实: MR对健康寿命的影响范围有限,仅在少数年轻人中研究了MR的影响 小鼠品系,迄今为止所做的癌症研究完全依赖于年轻的宿主。 了解MR如何影响乳腺癌的健康寿命、寿命和自然发展 在遗传异质性小鼠的衰老过程中, 基于MR的干预措施在遗传学领域的健康、长寿和癌症治疗的应用 异质人群。我们将使用尖端技术来分离和描述癌症 启动细胞(CIC),研究蛋氨酸及其代谢物水平的变化如何影响表观基因组。 我们将使用两个乳腺肿瘤模型来研究宿主年龄如何影响CIC、肿瘤生长和/或转移 最后,我们将确定蛋氨酸的特定分子传感器的作用 代谢物的表观遗传和抗癌作用的MR在老化。这项工作将长期持续下去- 关于饮食成分调节健康衰老的分子机制的长期问题 和癌症

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VINCENT L. CRYNS其他文献

VINCENT L. CRYNS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VINCENT L. CRYNS', 18)}}的其他基金

alphaBeta-crystallin: A Novel Biomarker in Breast Cancer
αβ-晶状体蛋白:乳腺癌的新型生物标志物
  • 批准号:
    7187693
  • 财政年份:
    2007
  • 资助金额:
    $ 61.97万
  • 项目类别:
alphaBeta-crystallin: A Novel Biomarker in Breast Cancer
αβ-晶状体蛋白:乳腺癌的新型生物标志物
  • 批准号:
    7340131
  • 财政年份:
    2007
  • 资助金额:
    $ 61.97万
  • 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
  • 批准号:
    6711150
  • 财政年份:
    2003
  • 资助金额:
    $ 61.97万
  • 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
  • 批准号:
    6856542
  • 财政年份:
    2003
  • 资助金额:
    $ 61.97万
  • 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
  • 批准号:
    6615904
  • 财政年份:
    2003
  • 资助金额:
    $ 61.97万
  • 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
  • 批准号:
    7032982
  • 财政年份:
    2003
  • 资助金额:
    $ 61.97万
  • 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
  • 批准号:
    7188600
  • 财政年份:
    2003
  • 资助金额:
    $ 61.97万
  • 项目类别:
MOLECULAR PATHOGENESIS OF PARATHYROID NEOPLASIA
甲状旁腺肿瘤的分子发病机制
  • 批准号:
    2084410
  • 财政年份:
    1993
  • 资助金额:
    $ 61.97万
  • 项目类别:
MOLECULAR PATHOGENESIS OF HUMAN PARATHYROID ADENOMAS
人甲状旁腺腺瘤的分子发病机制
  • 批准号:
    3034824
  • 财政年份:
    1993
  • 资助金额:
    $ 61.97万
  • 项目类别:
MOLECULAR PATHOGENESIS OF PARATHYROID NEOPLASIA
甲状旁腺肿瘤的分子发病机制
  • 批准号:
    2084408
  • 财政年份:
    1993
  • 资助金额:
    $ 61.97万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.97万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了